Lupin gets USFDA nod for cevimeline hydrochloride capsulesThe company's product is a generic version of Daiichi Sankyo Inc's Evoxac capsules, it added.
Ranbaxy gains 34%: Five reasons why the stock was on a highThe surge comes on a day when Malaysia allotted its JV the site for a manufacturing unit, and a day after the firm reported Q2 earnings.
- Ranbaxy: Improving US, local businesses to keep stock up
Ranbaxy’s September quarter performance, which was sans the exclusivity sales of generic Lipitor, was boosted by two authorised generic lau...